Alphabet's AI drug discovery platform Isomorphic Labs raises $600M from Thrive | TechCrunch

Isomorphic Labs, a spin-off of Google's DeepMind, raised $600 million led by Thrive Capital and GV to advance its AI drug discovery platform.